Fields »
ABOUT
HELP
BLOG

161 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
VAMP8Vesicle-associated membrane protein 8Predicted intracellular proteins
Predicted membrane proteins
Transporters
Thyroid cancer: 8.07e-9
Urothelial cancer: 1.59e-6
Expressed in all
HECTD3HECT domain containing E3 ubiquitin protein ligase 3Predicted intracellular proteins
Thyroid cancer: 1.85e-6
Liver cancer: 2.14e-5
Expressed in all
TRIM21Tripartite motif containing 21Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 2.26e-6
Breast cancer: 4.83e-5
Liver cancer: 1.87e-4
Expressed in all
GLTPGlycolipid transfer proteinPredicted intracellular proteins
CytosolThyroid cancer: 4.17e-6
Cervical cancer: 2.01e-5
Liver cancer: 7.68e-4
Expressed in all
TUBB4BTubulin, beta 4B class IVbFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesThyroid cancer: 6.36e-6
Endometrial cancer: 4.91e-4
Liver cancer: 9.98e-4
Expressed in all
MYL12BMyosin, light chain 12B, regulatoryPlasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center		Thyroid cancer: 6.62e-6
Renal cancer: 8.17e-5
Pancreatic cancer: 9.69e-4
Expressed in all
CCND3Cyclin D3Cancer-related genes
Predicted intracellular proteins
Plasma membrane
Focal adhesion sites
Cytosol		Thyroid cancer: 8.08e-6
Expressed in all
RAB34RAB34, member RAS oncogene familyPredicted intracellular proteins
Renal cancer: 1.64e-7
Thyroid cancer: 1.06e-5
Expressed in all
INPP1Inositol polyphosphate-1-phosphataseEnzymes
Predicted intracellular proteins
Vesicles
Microtubule organizing center		Thyroid cancer: 1.12e-5
Urothelial cancer: 5.70e-4
Expressed in all
KIAA1211LKIAA1211-likePredicted intracellular proteins
Microtubules
Cytokinetic bridge
Centrosome		Renal cancer: 1.13e-5
Thyroid cancer: 1.33e-5
Tissue enhanced
UBE2Q1Ubiquitin-conjugating enzyme E2Q family member 1Enzymes
Predicted intracellular proteins
Nucleoplasm
Centrosome		Renal cancer: 4.84e-7
Thyroid cancer: 1.86e-5
Liver cancer: 8.74e-4
Expressed in all
CALM2Calmodulin 2 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Thyroid cancer: 1.94e-5
Liver cancer: 8.35e-5
Endometrial cancer: 4.84e-4
Breast cancer: 5.05e-4
Expressed in all
PLA2G16Phospholipase A2, group XVIEnzymes
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
MitochondriaPancreatic cancer: 5.58e-6
Thyroid cancer: 2.54e-5
Expressed in all
MCM3Minichromosome maintenance complex component 3Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 3.13e-5
Melanoma: 4.40e-5
Liver cancer: 1.40e-4
Cervical cancer: 1.89e-4
Expressed in all
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhanced
C14orf119Chromosome 14 open reading frame 119Predicted intracellular proteins
Mitochondria
Cytosol		Thyroid cancer: 3.30e-5
Liver cancer: 5.42e-5
Expressed in all
ZCCHC12Zinc finger, CCHC domain containing 12Predicted intracellular proteins
Nuclear bodiesThyroid cancer: 3.42e-5
Group enriched
SLC37A1Solute carrier family 37 (glucose-6-phosphate transporter), member 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleusThyroid cancer: 3.43e-5
Endometrial cancer: 9.22e-5
Mixed
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmRenal cancer: 2.59e-5
Thyroid cancer: 3.45e-5
Tissue enhanced
DERADeoxyribose-phosphate aldolase (putative)Enzymes
Predicted intracellular proteins
NucleusThyroid cancer: 3.64e-5
Pancreatic cancer: 1.32e-4
Expressed in all
CNFNCornifelinPredicted intracellular proteins
Microtubules
Cytokinetic bridge		Thyroid cancer: 4.02e-5
Group enriched
MRPS18AMitochondrial ribosomal protein S18APredicted intracellular proteins
Ribosomal proteins
Thyroid cancer: 4.03e-5
Expressed in all
TPT1Tumor protein, translationally-controlled 1Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.54e-5
Thyroid cancer: 4.31e-5
Breast cancer: 5.90e-5
Endometrial cancer: 2.35e-4
Expressed in all
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol		Urothelial cancer: 6.19e-6
Thyroid cancer: 4.57e-5
Endometrial cancer: 5.71e-5
Tissue enriched
RNF181Ring finger protein 181Predicted intracellular proteins
Nucleoplasm
Cytosol		Renal cancer: 1.06e-6
Thyroid cancer: 4.59e-5
Expressed in all
DRAP1DR1-associated protein 1 (negative cofactor 2 alpha)Predicted intracellular proteins
CytosolRenal cancer: 3.73e-5
Thyroid cancer: 4.96e-5
Expressed in all
TMSB10Thymosin beta 10Plasma proteins
Predicted intracellular proteins
Renal cancer: 8.49e-7
Thyroid cancer: 4.97e-5
Expressed in all
CERS5Ceramide synthase 5Enzymes
Predicted membrane proteins
Nucleus
Nucleoli		Renal cancer: 9.33e-11
Liver cancer: 4.63e-5
Thyroid cancer: 5.76e-5
Expressed in all
LPAR5Lysophosphatidic acid receptor 5G-protein coupled receptors
Predicted membrane proteins
Thyroid cancer: 6.56e-5
Mixed
DOLKDolichol kinaseDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Nucleus
Cytosol		Thyroid cancer: 6.88e-5
Renal cancer: 5.53e-4
Mixed
CD47CD47 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Vesicles
Plasma membrane		Thyroid cancer: 7.29e-5
Renal cancer: 1.69e-4
Endometrial cancer: 2.44e-4
Expressed in all
CLUClusterinCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Thyroid cancer: 7.66e-5
Expressed in all
TDRD10Tudor domain containing 10Cancer-related genes
Predicted intracellular proteins
VesiclesThyroid cancer: 8.04e-5
Tissue enriched
TRIM38Tripartite motif containing 38Predicted intracellular proteins
Plasma membrane
Cell Junctions
Centrosome		Urothelial cancer: 4.94e-9
Thyroid cancer: 8.20e-5
Ovarian cancer: 8.95e-5
Mixed
IRF2Interferon regulatory factor 2Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol		Breast cancer: 6.95e-5
Thyroid cancer: 8.34e-5
Expressed in all
CD9CD9 moleculeCancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 6.49e-5
Thyroid cancer: 8.93e-5
Pancreatic cancer: 1.59e-4
Expressed in all
ISCA2Iron-sulfur cluster assembly 2Disease related genes
Predicted intracellular proteins
Renal cancer: 1.68e-7
Thyroid cancer: 8.98e-5
Expressed in all
RXRGRetinoid X receptor, gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Thyroid cancer: 9.40e-5
Tissue enhanced
NAE1NEDD8 activating enzyme E1 subunit 1Plasma proteins
Predicted intracellular proteins
Nucleus
Microtubules
Centrosome		Liver cancer: 3.92e-8
Thyroid cancer: 9.44e-5
Expressed in all
KCTD21Potassium channel tetramerization domain containing 21Predicted intracellular proteins
CytosolThyroid cancer: 9.57e-5
Mixed
CCND2Cyclin D2Cancer-related genes
Disease related genes
Predicted intracellular proteins
NucleoplasmThyroid cancer: 9.76e-5
Pancreatic cancer: 2.52e-4
Mixed
CLTAClathrin, light chain APlasma proteins
Predicted intracellular proteins
Endosomes
Lysosomes		Liver cancer: 9.46e-5
Thyroid cancer: 1.01e-4
Breast cancer: 5.64e-4
Expressed in all
INHBBInhibin, beta BCancer-related genes
Predicted secreted proteins
NucleoplasmThyroid cancer: 1.02e-4
Colorectal cancer: 1.44e-4
Renal cancer: 3.02e-4
Tissue enhanced
MRPL14Mitochondrial ribosomal protein L14Predicted intracellular proteins
Ribosomal proteins
MitochondriaRenal cancer: 7.46e-5
Thyroid cancer: 1.08e-4
Ovarian cancer: 4.81e-4
Expressed in all
SLC29A3Solute carrier family 29 (equilibrative nucleoside transporter), member 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles		Liver cancer: 6.07e-6
Renal cancer: 5.53e-5
Thyroid cancer: 1.16e-4
Mixed
PPP1CAProtein phosphatase 1, catalytic subunit, alpha isozymeEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Cytosol		Thyroid cancer: 1.17e-4
Expressed in all
PIP4K2BPhosphatidylinositol-5-phosphate 4-kinase, type II, betaCancer-related genes
Enzymes
Predicted intracellular proteins
NucleoplasmThyroid cancer: 1.36e-4
Liver cancer: 4.54e-4
Expressed in all
LMO4LIM domain only 4Predicted intracellular proteins
Nucleoplasm
Midbody ring		Thyroid cancer: 1.42e-4
Ovarian cancer: 1.47e-4
Liver cancer: 5.25e-4
Expressed in all
PSPC1Paraspeckle component 1Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nucleoli fibrillar center		Thyroid cancer: 1.46e-4
Liver cancer: 2.21e-4
Expressed in all
RABGGTARab geranylgeranyltransferase, alpha subunitEnzymes
Predicted intracellular proteins
NucleoplasmThyroid cancer: 1.51e-4
Renal cancer: 5.44e-4
Expressed in all

Page of 4 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.